Gene: TRMT12
Official Full Name: tRNA methyltransferase 12 homologprovided by HGNC
Gene Summary: Wybutosine (yW) is a hypermodified guanosine at the 3-prime position adjacent to the anticodon of phenylalanine tRNA that stabilizes codon-anticodon interactions during decoding on the ribosome. TRMT12 is the human homolog of a yeast gene essential for yW synthesis (Noma and Suzuki, 2006).[supplied by OMIM, Mar 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO13010 | TRMT12 Knockout cell line (HeLa) | Human | TRMT12 | 1:3~1:6 | Negative | Online Inquiry |
KO13011 | TRMT12 Knockout cell line (HCT 116) | Human | TRMT12 | 1:2~1:4 | Negative | Online Inquiry |
KO13012 | TRMT12 Knockout cell line (HEK293) | Human | TRMT12 | 1:3~1:6 | Negative | Online Inquiry |
KO13013 | TRMT12 Knockout cell line (A549) | Human | TRMT12 | 1:3~1:4 | Negative | Online Inquiry |
TRMT12 Gene Knockout Cell Lines are engineered cellular models specifically designed to study the functional role of the TRMT12 gene, which is implicated in various biological processes, including RNA modification and cellular stress responses. These knockout cell lines are created through advanced CRISPR/Cas9 technology, resulting in the complete inactivation of the TRMT12 gene, allowing researchers to observe the consequent phenotypic and molecular alterations.
The primary function of TRMT12 involves its role in transfer RNA (tRNA) modification, a critical process that ensures the fidelity of protein translation. By knocking out the TRMT12 gene, researchers can effectively investigate the subsequent effects on tRNA integrity, translation efficiency, and overall cellular function. This enables a deeper understanding of how disruptions in tRNA modification can contribute to diseases such as cancer or genetic disorders.
The scientific importance of TRMT12 Gene Knockout Cell Lines lies in their versatility and applicability in both research and clinical settings. These models serve as essential tools for elucidating the molecular mechanisms underlying RNA biology and disease states, thereby paving the way for potential therapeutic developments targeting tRNA modifications.
Compared to alternative models, TRMT12 Gene Knockout Cell Lines offer distinct advantages, including high specificity in gene disruption, a robust and reproducible experimental framework, and compatibility with a broad range of assays. Researchers can implement these cell lines to explore novel hypotheses in their investigations, enabling rapid progress in the understanding of gene function and its implications in human health.
By choosing TRMT12 Gene Knockout Cell Lines, researchers and clinicians are equipped with a powerful resource for advancing their studies in molecular biology and translational medicine. Our company prides itself on delivering cutting-edge genetic tools backed by rigorous scientific validation, ensuring that our customers receive high-quality products that enhance their research capabilities and support the next generation of biological research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.